| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.946 | 0.002 | 0.946 | Vasodilator, peripheral | 0.904 0.003 DBMET01949 0.755 0.004 DBMET01952 0.78 0.004 DBMET01950 0.656 0.01 DBMET01951 0.606 0.015 DBMET01953 | ||
| 0.911 | 0.001 | 0.924 | Calcium antagonist | 0.924 0.001 DBMET01949 0.52 0.002 DBMET01952 0.458 0.003 DBMET01950 0.532 0.002 DBMET01951 0.29 0.005 DBMET01953 | DBMET01949 | |
| 0.782 | 0.003 | 0.834 | Calcium channel blocker | 0.834 0.002 DBMET01949 0.555 0.004 DBMET01952 0.544 0.004 DBMET01950 0.626 0.003 DBMET01951 0.499 0.004 DBMET01953 | DBMET01949 | |
| 0.752 | 0.004 | 0.968 | Vasodilator, coronary | 0.968 0.002 DBMET01949 0.377 0.044 DBMET01952 0.667 0.005 DBMET01950 0.611 0.007 DBMET01951 0.451 0.023 DBMET01953 | DBMET01949 | |
| 0.746 | 0.004 | 0.746 | Vasodilator | 0.738 0.004 DBMET01949 0.546 0.009 DBMET01952 0.688 0.004 DBMET01950 0.549 0.009 DBMET01951 0.412 0.021 DBMET01953 | ||
| 0.712 | 0.001 | 0.75 | Calcium channel activator | 0.75 0.001 DBMET01949 0.574 0.003 DBMET01952 0.565 0.003 DBMET01950 0.59 0.003 DBMET01951 0.594 0.002 DBMET01953 | DBMET01949 | |
| 0.707 | 0.002 | 0.72 | Calcium channel L-type activator | 0.698 0.003 DBMET01949 0.703 0.003 DBMET01952 0.665 0.003 DBMET01950 0.693 0.003 DBMET01951 0.72 0.002 DBMET01953 | DBMET01953 | |
| 0.684 | 0.003 | 0.684 | TRPA1 agonist | 0.505 0.003 DBMET01949 0.166 0.021 DBMET01952 0.384 0.004 DBMET01950 0.129 0.048 DBMET01951 0.172 0.019 DBMET01953 | ||
| 0.642 | 0.003 | 0.642 | Calcium channel (voltage-sensitive) blocker | 0.636 0.003 DBMET01949 0.389 0.005 DBMET01952 0.35 0.005 DBMET01950 0.385 0.005 DBMET01951 0.327 0.005 DBMET01953 | ||
| 0.584 | 0.002 | 0.783 | Calcium channel L-type blocker | 0.783 0.001 DBMET01949 0.38 0.003 DBMET01952 0.516 0.002 DBMET01950 0.58 0.002 DBMET01951 0.46 0.003 DBMET01953 | DBMET01949 | |
| 0.574 | 0.065 | 0.667 | DNA polymerase beta inhibitor | 0.231 0.204 DBMET01949 0.667 0.044 DBMET01952 0.403 0.118 DBMET01950 0.322 0.154 DBMET01951 0.548 0.073 DBMET01953 | DBMET01952 | |
| 0.529 | 0.074 | 0.62 | DNA directed DNA polymerase inhibitor | 0.258 0.187 DBMET01949 0.62 0.051 DBMET01952 0.362 0.133 DBMET01950 0.351 0.138 DBMET01951 0.498 0.083 DBMET01953 | DBMET01952 | |
| 0.466 | 0.086 | 0.539 | Transcription factor inhibitor | 0.539 0.064 DBMET01952 0.283 0.165 DBMET01950 0.369 0.122 DBMET01953 | DBMET01952 | |
| 0.396 | 0.029 | 0.639 | Cardiotonic | 0.551 0.01 DBMET01949 0.639 0.006 DBMET01950 0.261 0.075 DBMET01951 0.182 0.137 DBMET01953 | DBMET01950 | |
| 0.367 | 0.049 | 0.367 | Apoptosis antagonist | 0.28 0.1 DBMET01949 0.318 0.074 DBMET01952 0.244 0.134 DBMET01950 0.212 0.164 DBMET01951 0.207 0.171 DBMET01953 | ||
| 0.323 | 0.006 | 0.337 | Adenylate kinase inhibitor | 0.337 0.005 DBMET01949 0.178 0.019 DBMET01952 0.298 0.007 DBMET01950 0.191 0.016 DBMET01951 0.232 0.011 DBMET01953 | DBMET01949 | |
| 0.303 | 0.041 | 0.322 | Cyclic AMP phosphodiesterase inhibitor | 0.322 0.034 DBMET01949 0.185 0.106 DBMET01952 0.286 0.047 DBMET01950 0.203 0.092 DBMET01951 0.247 0.065 DBMET01953 | DBMET01949 | |
| 0.266 | 0.045 | 0.342 | Platelet aggregation inhibitor | 0.342 0.027 DBMET01949 0.164 0.113 DBMET01951 | DBMET01949 | |
| 0.289 | 0.074 | 0.515 | Spasmolytic | 0.515 0.021 DBMET01949 0.396 0.041 DBMET01950 0.19 0.129 DBMET01951 | DBMET01949 | |
| 0.307 | 0.098 | 0.355 | Thioredoxin glutathione reductase inhibitor | 0.355 0.075 DBMET01952 0.262 0.127 DBMET01950 0.188 0.182 DBMET01951 0.323 0.089 DBMET01953 | DBMET01952 | |
| 0.194 | 0.004 | 0.233 | Aldosterone antagonist | 0.207 0.004 DBMET01949 0.233 0.004 DBMET01950 | DBMET01950 | |
| 0.317 | 0.128 | 0.38 | Beta lactamase inhibitor | 0.38 0.106 DBMET01952 0.238 0.163 DBMET01953 | DBMET01952 | |
| 0.199 | 0.019 | 0.233 | Neuropeptide Y1 antagonist | 0.225 0.012 DBMET01949 0.191 0.023 DBMET01952 0.172 0.037 DBMET01950 0.215 0.014 DBMET01951 0.233 0.01 DBMET01953 | DBMET01953 | |
| 0.336 | 0.158 | 0.484 | Caspase 9 stimulant | 0.272 0.227 DBMET01949 0.484 0.066 DBMET01952 0.411 0.105 DBMET01951 0.414 0.103 DBMET01953 | DBMET01952 | |
| 0.226 | 0.05 | 0.347 | P-glycoprotein inhibitor | 0.296 0.03 DBMET01949 0.168 0.092 DBMET01952 0.347 0.021 DBMET01950 0.228 0.049 DBMET01951 0.177 0.082 DBMET01953 | DBMET01950 | |
| 0.278 | 0.108 | 0.285 | Transcription factor NF kappa B inhibitor | 0.237 0.137 DBMET01949 0.258 0.122 DBMET01952 0.222 0.149 DBMET01950 0.214 0.156 DBMET01951 0.285 0.103 DBMET01953 | DBMET01953 | |
| 0.181 | 0.012 | 0.181 | ABCA1 expression enhancer | 0.093 0.061 DBMET01949 0.116 0.033 DBMET01952 0.107 0.042 DBMET01950 | ||
| 0.202 | 0.042 | 0.214 | Phospholipase A2 inhibitor | 0.148 0.076 DBMET01949 0.16 0.066 DBMET01952 0.214 0.036 DBMET01950 0.122 0.113 DBMET01951 0.146 0.079 DBMET01953 | DBMET01950 | |
| 0.189 | 0.029 | 0.205 | CF transmembrane conductance regulator agonist | 0.205 0.019 DBMET01949 0.178 0.038 DBMET01950 0.132 0.113 DBMET01953 | DBMET01949 | |
| 0.209 | 0.051 | 0.209 | Lipocortins synthesis antagonist | 0.181 0.07 DBMET01949 0.174 0.077 DBMET01952 0.193 0.061 DBMET01950 0.146 0.111 DBMET01951 0.161 0.091 DBMET01953 | ||
| 0.201 | 0.044 | 0.566 | Diuretic | 0.315 0.02 DBMET01949 0.566 0.005 DBMET01950 | DBMET01950 | |
| 0.165 | 0.033 | 0.248 | Alpha 2b adrenoreceptor antagonist | 0.143 0.042 DBMET01949 0.248 0.015 DBMET01950 0.133 0.049 DBMET01953 | DBMET01950 | |
| 0.268 | 0.137 | 0.286 | Calpain 2 inhibitor | 0.286 0.124 DBMET01952 0.204 0.184 DBMET01953 | DBMET01952 | |
| 0.173 | 0.045 | 0.278 | Interleukin 1 antagonist | 0.278 0.014 DBMET01952 0.156 0.053 DBMET01951 0.182 0.041 DBMET01953 | DBMET01952 | |
| 0.233 | 0.116 | 0.279 | Hypoxia-inducible factor 1 alpha inhibitor | 0.235 0.114 DBMET01949 0.259 0.092 DBMET01950 0.181 0.177 DBMET01951 0.279 0.077 DBMET01953 | DBMET01953 | |
| 0.124 | 0.016 | 0.179 | Glycine receptor antagonist | 0.127 0.015 DBMET01949 0.179 0.004 DBMET01950 | DBMET01950 | |
| 0.237 | 0.134 | 0.328 | Interleukin 2 agonist | 0.292 0.079 DBMET01949 0.202 0.186 DBMET01952 0.328 0.056 DBMET01950 0.269 0.099 DBMET01951 0.286 0.084 DBMET01953 | DBMET01950 | |
| 0.152 | 0.05 | 0.219 | Farnesoid X receptor antagonist | 0.138 0.069 DBMET01949 0.219 0.017 DBMET01950 | DBMET01950 | |
| 0.18 | 0.08 | 0.191 | Hepatoprotectant | 0.191 0.071 DBMET01949 0.141 0.119 DBMET01951 | DBMET01949 | |
| 0.178 | 0.088 | 0.215 | Anesthetic general | 0.168 0.096 DBMET01949 0.215 0.067 DBMET01952 0.201 0.074 DBMET01951 0.199 0.075 DBMET01953 | DBMET01952 | |
| 0.128 | 0.039 | 0.128 | Beta glucuronidase inhibitor | 0.101 0.069 DBMET01949 0.092 0.084 DBMET01952 0.099 0.071 DBMET01950 0.119 0.047 DBMET01953 | ||
| 0.2 | 0.113 | 0.225 | Antioxidant | 0.225 0.099 DBMET01949 0.159 0.154 DBMET01952 0.178 0.134 DBMET01950 0.184 0.128 DBMET01951 0.163 0.15 DBMET01953 | DBMET01949 | |
| 0.129 | 0.043 | 0.176 | Alpha 2c adrenoreceptor antagonist | 0.103 0.063 DBMET01949 0.176 0.023 DBMET01950 0.116 0.052 DBMET01953 | DBMET01950 | |
| 0.124 | 0.04 | 0.21 | DOPA decarboxylase inhibitor | 0.15 0.021 DBMET01952 0.115 0.05 DBMET01950 0.108 0.062 DBMET01951 0.21 0.005 DBMET01953 | DBMET01953 | |
| 0.167 | 0.084 | 0.281 | Succinate dehydrogenase inhibitor | 0.154 0.105 DBMET01949 0.186 0.062 DBMET01952 0.281 0.014 DBMET01950 0.171 0.078 DBMET01951 0.238 0.027 DBMET01953 | DBMET01950 | |
| 0.109 | 0.026 | 0.109 | 3C-Like protease (SARS coronavirus) inhibitor | 0.08 0.07 DBMET01949 0.107 0.027 DBMET01952 0.078 0.076 DBMET01950 0.08 0.07 DBMET01953 | ||
| 0.086 | 0.01 | 0.256 | Mineralocorticoid receptor antagonist | 0.081 0.011 DBMET01949 0.256 0.004 DBMET01950 | DBMET01950 | |
| 0.256 | 0.184 | 0.445 | Alpha-glucosidase inhibitor | 0.436 0.101 DBMET01952 0.264 0.179 DBMET01950 0.349 0.136 DBMET01951 0.445 0.098 DBMET01953 | DBMET01953 | |
| 0.127 | 0.059 | 0.13 | Platelet activating factor antagonist | 0.13 0.057 DBMET01949 | DBMET01949 | |
| 0.127 | 0.06 | 0.171 | Sphingosine 1-phosphate receptor 4 antagonist | 0.113 0.087 DBMET01949 0.153 0.031 DBMET01952 0.13 0.055 DBMET01950 0.136 0.048 DBMET01951 0.171 0.019 DBMET01953 | DBMET01953 | |
| 0.108 | 0.041 | 0.222 | Androgen antagonist | 0.222 0.011 DBMET01949 0.22 0.012 DBMET01950 0.121 0.033 DBMET01951 0.085 0.06 DBMET01953 | DBMET01949 | |
| 0.086 | 0.02 | 0.086 | Calcium channel T-type blocker | |||
| 0.093 | 0.03 | 0.093 | Adenosine A3 receptor antagonist | 0.087 0.035 DBMET01949 0.069 0.061 DBMET01950 | ||
| 0.154 | 0.094 | 0.175 | 3C-like protease (Human coronavirus) inhibitor | 0.175 0.07 DBMET01952 0.165 0.08 DBMET01953 | DBMET01952 | |
| 0.155 | 0.096 | 0.173 | Amyloid beta precursor protein antagonist | 0.172 0.079 DBMET01949 0.135 0.12 DBMET01950 0.173 0.078 DBMET01953 | DBMET01953 | |
| 0.161 | 0.102 | 0.273 | Non-steroidal antiinflammatory agent | 0.213 0.061 DBMET01949 0.197 0.073 DBMET01952 0.211 0.062 DBMET01950 0.25 0.043 DBMET01951 0.273 0.035 DBMET01953 | DBMET01953 | |
| 0.112 | 0.053 | 0.144 | Toll-Like receptor 4 antagonist | 0.139 0.028 DBMET01949 0.115 0.048 DBMET01952 0.144 0.025 DBMET01951 0.11 0.055 DBMET01953 | DBMET01951 | |
| 0.135 | 0.087 | 0.29 | Cytidine deaminase inhibitor | 0.168 0.063 DBMET01949 0.247 0.03 DBMET01952 0.285 0.022 DBMET01951 0.29 0.021 DBMET01953 | DBMET01953 | |
| 0.099 | 0.051 | 0.144 | Bile acid receptor antagonist | 0.094 0.064 DBMET01949 0.144 0.009 DBMET01950 | DBMET01950 | |
| 0.112 | 0.068 | 0.136 | Photosensitizer | 0.117 0.061 DBMET01952 0.136 0.041 DBMET01953 | DBMET01953 | |
| 0.072 | 0.03 | 0.08 | Caspase 9 inhibitor | 0.08 0.023 DBMET01952 | DBMET01952 | |
| 0.129 | 0.088 | 0.307 | Mannose-6-phosphate isomerase inhibitor | 0.184 0.04 DBMET01949 0.2 0.03 DBMET01952 0.118 0.105 DBMET01950 0.254 0.011 DBMET01951 0.307 0.005 DBMET01953 | DBMET01953 | |
| 0.167 | 0.126 | 0.167 | Free radical scavenger | 0.158 0.136 DBMET01952 0.151 0.144 DBMET01953 | ||
| 0.074 | 0.033 | 0.133 | Beta adrenoreceptor antagonist | 0.133 0.008 DBMET01949 0.062 0.052 DBMET01951 | DBMET01949 | |
| 0.206 | 0.17 | 0.335 | Antithrombotic | 0.335 0.07 DBMET01949 0.252 0.125 DBMET01950 0.222 0.152 DBMET01951 0.193 0.186 DBMET01953 | DBMET01949 | |
| 0.133 | 0.1 | 0.199 | GABA C receptor rho-2 antagonist | 0.179 0.043 DBMET01952 0.15 0.074 DBMET01951 0.199 0.029 DBMET01953 | DBMET01953 | |
| 0.095 | 0.062 | 0.112 | Interleukin 12 antagonist | 0.103 0.049 DBMET01949 0.089 0.074 DBMET01952 0.098 0.056 DBMET01951 0.112 0.037 DBMET01953 | DBMET01953 | |
| 0.137 | 0.11 | 0.204 | Interleukin 6 antagonist | 0.2 0.041 DBMET01949 0.135 0.115 DBMET01952 0.133 0.119 DBMET01950 0.204 0.039 DBMET01951 0.167 0.067 DBMET01953 | DBMET01951 | |
| 0.035 | 0.018 | 0.035 | Transforming growth factor beta 2 antagonist | 0.032 0.026 DBMET01949 | ||
| 0.062 | 0.045 | 0.084 | Nitric oxide donor | 0.084 0.019 DBMET01949 0.07 0.032 DBMET01951 | DBMET01949 | |
| 0.124 | 0.109 | 0.273 | Sigma receptor agonist | 0.176 0.071 DBMET01952 0.136 0.096 DBMET01951 0.273 0.044 DBMET01953 | DBMET01953 | |
| 0.088 | 0.076 | 0.142 | UDP-glucose 4-epimerase inhibitor | 0.088 0.077 DBMET01949 0.103 0.058 DBMET01952 0.125 0.04 DBMET01950 0.102 0.059 DBMET01951 0.142 0.031 DBMET01953 | DBMET01953 | |
| 0.031 | 0.021 | 0.036 | Caspase 6 inhibitor | 0.036 0.011 DBMET01952 | DBMET01952 | |
| 0.065 | 0.056 | 0.226 | Histidine decarboxylase inhibitor | 0.065 0.056 DBMET01949 0.082 0.041 DBMET01952 0.082 0.041 DBMET01951 0.226 0.01 DBMET01953 | DBMET01953 | |
| 0.181 | 0.172 | 0.379 | 12-Lipoxygenase inhibitor | 0.336 0.062 DBMET01952 0.282 0.09 DBMET01951 0.379 0.045 DBMET01953 | DBMET01953 | |
| 0.051 | 0.046 | 0.095 | Thromboxane synthase inhibitor | 0.081 0.011 DBMET01949 0.095 0.007 DBMET01950 0.057 0.032 DBMET01951 0.07 0.018 DBMET01953 | DBMET01950 | |
| 0.056 | 0.051 | 0.059 | Potassium channel intermediate-conductance Ca-activated blocker | 0.059 0.044 DBMET01953 | DBMET01953 | |
| 0.088 | 0.083 | 0.123 | Mediator release inhibitor | 0.123 0.045 DBMET01949 | DBMET01949 | |
| 0.023 | 0.019 | 0.034 | NMDA receptor glycine site antagonist | 0.034 0.01 DBMET01950 0.029 0.013 DBMET01953 | DBMET01950 | |
| 0.188 | 0.189 | 0.195 | Caspase 3 stimulant | 0.195 0.177 DBMET01952 | DBMET01952 | |
| 0.054 | 0.058 | 0.066 | Phosphodiesterase III inhibitor | 0.066 0.046 DBMET01949 | DBMET01949 | |
| 0.072 | 0.077 | 0.082 | Glutathione S-transferase inhibitor | 0.078 0.064 DBMET01950 0.082 0.059 DBMET01953 | DBMET01953 | |
| 0.046 | 0.053 | 0.076 | Alpha 1d adrenoreceptor antagonist | 0.076 0.032 DBMET01949 0.07 0.035 DBMET01950 | DBMET01949 | |
| 0.077 | 0.09 | 0.087 | Thioredoxin inhibitor | 0.087 0.066 DBMET01952 | DBMET01952 | |
| 0.044 | 0.057 | 0.102 | Beta 1 adrenoreceptor antagonist | 0.102 0.01 DBMET01949 | DBMET01949 | |
| 0.073 | 0.09 | 0.093 | Transcription factor NF kappa B stimulant | 0.093 0.047 DBMET01949 0.093 0.047 DBMET01951 | DBMET01951 | |
| 0.089 | 0.108 | 0.189 | M18 aspartyl aminopeptidase inhibitor | 0.102 0.089 DBMET01952 0.189 0.037 DBMET01953 | DBMET01953 | |
| 0.051 | 0.07 | 0.084 | Alpha 1b adrenoreceptor antagonist | 0.076 0.049 DBMET01949 0.084 0.043 DBMET01950 | DBMET01950 | |
| 0.074 | 0.094 | 0.086 | Granulocyte macrophage colony stimulating factor agonist | 0.086 0.06 DBMET01952 0.082 0.069 DBMET01953 | DBMET01952 | |
| 0.036 | 0.057 | 0.073 | Glutamate (mGluR group III) antagonist | 0.057 0.015 DBMET01950 0.073 0.009 DBMET01953 | DBMET01953 | |
| 0.023 | 0.047 | 0.041 | Catechol O-methyltransferase inhibitor | 0.034 0.02 DBMET01952 0.034 0.02 DBMET01950 0.031 0.026 DBMET01951 0.041 0.013 DBMET01953 | DBMET01953 | |
| 0.148 | 0.174 | 0.337 | Streptokinase A inhibitor | 0.29 0.083 DBMET01952 0.19 0.139 DBMET01951 0.337 0.066 DBMET01953 | DBMET01953 | |
| 0.112 | 0.138 | 0.13 | Thiol protease inhibitor | 0.13 0.097 DBMET01952 | DBMET01952 | |
| 0.039 | 0.066 | 0.061 | Potassium channel (Inward rectifier) activator | 0.061 0.018 DBMET01950 | DBMET01950 | |
| 0.038 | 0.064 | 0.058 | Potassium channel (ATP-sensitive) activator | 0.058 0.017 DBMET01950 | DBMET01950 | |
| 0.051 | 0.079 | 0.082 | Catalase inhibitor | 0.082 0.046 DBMET01952 0.077 0.049 DBMET01951 0.072 0.053 DBMET01953 | DBMET01952 | |
| 0.133 | 0.164 | 0.394 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.272 0.072 DBMET01952 0.394 0.039 DBMET01953 | DBMET01953 | |
| 0.032 | 0.066 | 0.054 | GABA B receptor antagonist | 0.048 0.022 DBMET01952 0.052 0.018 DBMET01951 0.054 0.016 DBMET01953 | DBMET01953 | |
| 0.01 | 0.043 | 0.02 | Kainate receptor 3 antagonist | 0.019 0.01 DBMET01950 0.02 0.009 DBMET01953 | DBMET01953 | |
| 0.053 | 0.087 | 0.114 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.074 0.057 DBMET01952 0.081 0.05 DBMET01950 0.114 0.031 DBMET01953 | DBMET01953 | |
| 0.013 | 0.047 | 0.037 | Kainate receptor 4 antagonist | 0.037 0.01 DBMET01950 0.036 0.011 DBMET01953 | DBMET01950 | |
| 0.046 | 0.082 | 0.076 | HIV-1 reverse transcriptase inhibitor | 0.076 0.044 DBMET01952 | DBMET01952 | |
| 0.053 | 0.091 | 0.081 | Alpha 2a adrenoreceptor antagonist | 0.081 0.048 DBMET01950 | DBMET01950 | |
| 0.028 | 0.067 | 0.062 | Glutamate (mGluR8) agonist | 0.048 0.013 DBMET01950 0.062 0.006 DBMET01953 | DBMET01953 | |
| 0.037 | 0.078 | 0.065 | Elastase inhibitor | 0.065 0.026 DBMET01950 | DBMET01950 | |
| 0.129 | 0.171 | 0.228 | Platelet antagonist | 0.228 0.083 DBMET01949 0.201 0.1 DBMET01950 | DBMET01949 | |
| 0.068 | 0.11 | 0.195 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.104 0.05 DBMET01949 0.195 0.017 DBMET01950 0.087 0.069 DBMET01951 0.149 0.027 DBMET01953 | DBMET01950 | |
| 0.058 | 0.102 | 0.17 | Antiadrenergic | 0.17 0.031 DBMET01949 0.079 0.072 DBMET01950 | DBMET01949 | |
| 0.056 | 0.101 | 0.168 | Adrenaline antagonist | 0.168 0.03 DBMET01949 0.077 0.071 DBMET01950 | DBMET01949 | |
| 0.115 | 0.16 | 0.169 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.142 0.088 DBMET01950 0.169 0.044 DBMET01953 | DBMET01953 | |
| 0.076 | 0.124 | 0.122 | Interleukin 1b antagonist | 0.11 0.07 DBMET01952 0.122 0.061 DBMET01953 | DBMET01953 | |
| 0.077 | 0.126 | 0.204 | Alkylator | 0.13 0.059 DBMET01949 0.132 0.058 DBMET01952 0.204 0.025 DBMET01951 0.198 0.027 DBMET01953 | DBMET01951 | |
| 0.066 | 0.117 | 0.094 | Thioredoxin reductase inhibitor | 0.081 0.059 DBMET01952 0.077 0.072 DBMET01951 0.094 0.035 DBMET01953 | DBMET01953 | |
| 0.115 | 0.167 | 0.521 | Aryl hydrocarbon receptor agonist | 0.345 0.049 DBMET01952 0.178 0.116 DBMET01951 0.521 0.022 DBMET01953 | DBMET01953 | |
| 0.052 | 0.104 | 0.073 | Glutamate (mGluR6) antagonist | 0.073 0.034 DBMET01953 | DBMET01953 | |
| 0.044 | 0.098 | 0.207 | Porphobilinogen synthase inhibitor | 0.076 0.051 DBMET01952 0.161 0.018 DBMET01950 0.207 0.011 DBMET01953 | DBMET01953 | |
| 0.1 | 0.159 | 0.142 | Arachidonic acid antagonist | 0.142 0.098 DBMET01950 | DBMET01950 | |
| 0.03 | 0.089 | 0.064 | Glutamate (mGluR4) antagonist | 0.057 0.015 DBMET01950 0.064 0.012 DBMET01953 | DBMET01953 | |
| 0.014 | 0.076 | 0.06 | NMDA 2D receptor antagonist | 0.028 0.018 DBMET01950 0.06 0.005 DBMET01953 | DBMET01953 | |
| 0.008 | 0.071 | 0.035 | Kainate receptor 5 antagonist | 0.029 0.01 DBMET01950 0.035 0.008 DBMET01953 | DBMET01953 | |
| 0.062 | 0.128 | 0.143 | Triose-phosphate isomerase inhibitor | 0.084 0.068 DBMET01949 0.111 0.038 DBMET01950 0.106 0.042 DBMET01951 0.143 0.022 DBMET01953 | DBMET01953 | |
| 0.141 | 0.21 | 0.359 | Prostaglandin dehydrogenase inhibitor | 0.359 0.079 DBMET01952 0.346 0.084 DBMET01953 | DBMET01952 | |
| 0.104 | 0.173 | 0.267 | DNA methyltransferase I inhibitor | 0.173 0.084 DBMET01952 0.212 0.063 DBMET01951 0.267 0.039 DBMET01953 | DBMET01953 | |
| 0.151 | 0.221 | 0.474 | Cholesterol antagonist | 0.356 0.062 DBMET01949 0.219 0.149 DBMET01952 0.22 0.148 DBMET01950 0.474 0.037 DBMET01951 0.37 0.057 DBMET01953 | DBMET01951 | |
| 0.02 | 0.09 | 0.034 | Purinergic P2Y2 antagonist | 0.034 0.023 DBMET01953 | DBMET01953 | |
| 0.092 | 0.162 | 0.328 | Mcl-1 antagonist | 0.127 0.115 DBMET01949 0.149 0.09 DBMET01952 0.159 0.081 DBMET01950 0.184 0.065 DBMET01951 0.328 0.019 DBMET01953 | DBMET01953 | |
| 0.066 | 0.137 | 0.445 | Anesthetic local | 0.134 0.057 DBMET01949 0.271 0.016 DBMET01952 0.445 0.005 DBMET01951 0.233 0.024 DBMET01953 | DBMET01951 | |
| 0.078 | 0.151 | 0.106 | Factor V inhibitor | 0.101 0.066 DBMET01950 0.106 0.056 DBMET01953 | DBMET01953 | |
| 0.132 | 0.205 | 0.238 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.15 0.149 DBMET01951 0.238 0.048 DBMET01953 | DBMET01953 | |
| 0.143 | 0.217 | 0.226 | RNA-directed DNA polymerase inhibitor | 0.226 0.068 DBMET01949 0.203 0.096 DBMET01950 0.218 0.076 DBMET01951 0.221 0.073 DBMET01953 | DBMET01949 | |
| 0.073 | 0.148 | 0.108 | Caspase 3 inhibitor | 0.108 0.079 DBMET01952 0.104 0.085 DBMET01953 | DBMET01952 | |
| 0.027 | 0.109 | 0.104 | Argininosuccinate synthase inhibitor | 0.104 0.018 DBMET01950 0.057 0.039 DBMET01953 | DBMET01950 | |
| 0.034 | 0.117 | 0.091 | CD45 antagonist | 0.048 0.04 DBMET01951 0.091 0.01 DBMET01953 | DBMET01953 | |
| 0.01 | 0.098 | 0.077 | Progesterone antagonist | 0.077 0.011 DBMET01950 | DBMET01950 | |
| 0.069 | 0.159 | 0.113 | Microtubule formation inhibitor | 0.113 0.07 DBMET01949 | DBMET01949 | |
| 0.133 | 0.227 | 0.272 | Thyroid hormone beta antagonist | 0.272 0.104 DBMET01952 0.214 0.143 DBMET01953 | DBMET01952 | |
| 0.066 | 0.161 | 0.143 | Multidrug resistance-associated protein 1 inhibitor | 0.095 0.088 DBMET01952 0.143 0.029 DBMET01953 | DBMET01953 | |
| 0.03 | 0.127 | 0.065 | Alpha 1 adrenoreceptor antagonist | 0.065 0.063 DBMET01949 | DBMET01949 | |
| 0.021 | 0.119 | 0.103 | Dihydroorotate dehydrogenase inhibitor | 0.103 0.01 DBMET01953 | DBMET01953 | |
| 0.131 | 0.234 | 0.278 | Thyroid hormone antagonist | 0.278 0.105 DBMET01952 0.232 0.136 DBMET01953 | DBMET01952 | |
| 0.026 | 0.131 | 0.153 | Biliverdin reductase inhibitor | 0.056 0.045 DBMET01949 0.098 0.019 DBMET01950 0.074 0.029 DBMET01951 0.153 0.009 DBMET01953 | DBMET01953 | |
| 0.042 | 0.148 | 0.086 | Ornithine decarboxylase inhibitor | 0.086 0.06 DBMET01953 | DBMET01953 | |
| 0.098 | 0.205 | 0.163 | Interferon gamma antagonist | 0.136 0.099 DBMET01949 0.134 0.104 DBMET01951 0.163 0.063 DBMET01953 | DBMET01953 | |
| 0.047 | 0.155 | 0.061 | Prolactin release inhibitor | 0.061 0.049 DBMET01950 | DBMET01950 | |
| 0.058 | 0.169 | 0.095 | DNA polymerase I inhibitor | 0.095 0.092 DBMET01949 | DBMET01949 | |
| 0.023 | 0.133 | 0.146 | Alcohol oxidase inhibitor | 0.082 0.023 DBMET01950 0.077 0.025 DBMET01951 0.146 0.01 DBMET01953 | DBMET01953 | |
| 0.024 | 0.134 | 0.074 | NMDA receptor glycine site agonist | 0.074 0.033 DBMET01953 | DBMET01953 | |
| 0.011 | 0.123 | 0.048 | Kainate receptor antagonist | 0.043 0.026 DBMET01950 0.048 0.023 DBMET01953 | DBMET01953 | |
| 0.003 | 0.118 | 0.014 | Angiotensin AT1B receptor antagonist | 0.014 0.01 DBMET01953 | DBMET01953 | |
| 0.138 | 0.254 | 0.187 | Nitric-oxide synthase stimulant | 0.187 0.112 DBMET01949 0.184 0.118 DBMET01951 0.168 0.158 DBMET01953 | DBMET01949 | |
| 0.034 | 0.15 | 0.08 | NMDA receptor agonist | 0.074 0.033 DBMET01950 0.08 0.029 DBMET01953 | DBMET01953 | |
| 0.072 | 0.189 | 0.193 | Interleukin 4 antagonist | 0.123 0.081 DBMET01949 0.116 0.091 DBMET01952 0.163 0.039 DBMET01951 0.193 0.025 DBMET01953 | DBMET01953 | |
| 0.056 | 0.173 | 0.102 | Interleukin 5 antagonist | 0.096 0.047 DBMET01951 0.102 0.039 DBMET01953 | DBMET01953 | |
| 0.065 | 0.183 | 0.181 | M17 leucyl aminopeptidase inhibitor | 0.181 0.04 DBMET01953 | DBMET01953 | |
| 0.015 | 0.134 | 0.051 | Phosphorylase inhibitor | 0.051 0.03 DBMET01949 | DBMET01949 | |
| 0.132 | 0.252 | 0.204 | Peptidyltransferase inhibitor | 0.204 0.094 DBMET01949 0.188 0.116 DBMET01950 0.169 0.148 DBMET01951 | DBMET01949 | |
| 0.15 | 0.27 | 0.283 | 15-Lipoxygenase inhibitor | 0.226 0.186 DBMET01952 0.242 0.171 DBMET01950 0.283 0.142 DBMET01953 | DBMET01953 | |
| 0.051 | 0.172 | 0.073 | GABA B receptor agonist | 0.073 0.059 DBMET01950 0.07 0.069 DBMET01953 | DBMET01950 | |
| 0.032 | 0.153 | 0.057 | Dihydroorotate oxidase inhibitor | 0.057 0.034 DBMET01953 | DBMET01953 | |
| 0.014 | 0.138 | 0.038 | Toll-Like receptor 2 agonist | 0.038 0.031 DBMET01951 | DBMET01951 | |
| 0.18 | 0.305 | 0.335 | Apoptosis agonist | 0.282 0.185 DBMET01952 0.335 0.149 DBMET01951 0.313 0.163 DBMET01953 | DBMET01951 | |
| 0.018 | 0.143 | 0.09 | Glutamate (mGluR1) antagonist | 0.074 0.027 DBMET01950 0.09 0.019 DBMET01953 | DBMET01953 | |
| 0.044 | 0.169 | 0.07 | Keratolytic | 0.07 0.066 DBMET01953 | DBMET01953 | |
| 0.05 | 0.176 | 0.193 | Breast cancer-resistant protein inhibitor | 0.139 0.028 DBMET01952 0.128 0.034 DBMET01951 0.193 0.015 DBMET01953 | DBMET01953 | |
| 0.039 | 0.169 | 0.078 | Glutamate dehydrogenase inhibitor | 0.074 0.051 DBMET01950 0.078 0.047 DBMET01953 | DBMET01953 | |
| 0.016 | 0.148 | 0.055 | Thromboxane A2 antagonist | 0.055 0.032 DBMET01950 | DBMET01950 | |
| 0.01 | 0.145 | 0.03 | Fumarate hydratase inhibitor | 0.03 0.029 DBMET01953 | DBMET01953 | |
| 0.062 | 0.199 | 0.114 | Glutamate release inhibitor | 0.094 0.054 DBMET01949 0.114 0.027 DBMET01951 | DBMET01951 | |
| 0.007 | 0.145 | 0.042 | Kynurenine 3 monooxygenase inhibitor | 0.042 0.009 DBMET01953 | DBMET01953 | |
| 0.018 | 0.156 | 0.058 | Thromboxane antagonist | 0.058 0.034 DBMET01950 | DBMET01950 | |
| 0.023 | 0.167 | 0.047 | Kainate receptor agonist | 0.047 0.018 DBMET01950 0.039 0.033 DBMET01953 | DBMET01950 | |
| 0.038 | 0.185 | 0.061 | Bcl-xL inhibitor | 0.061 0.037 DBMET01953 | DBMET01953 | |
| 0.179 | 0.326 | 0.285 | MAP kinase 1 inhibitor | 0.285 0.197 DBMET01952 | DBMET01952 | |
| 0.086 | 0.236 | 0.283 | Interleukin agonist | 0.283 0.057 DBMET01949 0.281 0.058 DBMET01951 0.252 0.077 DBMET01953 | DBMET01949 | |
| 0.035 | 0.185 | 0.069 | Adenine nucleotide translocase inhibitor | 0.053 0.046 DBMET01950 0.069 0.016 DBMET01953 | DBMET01953 | |
| 0.09 | 0.241 | 0.246 | Immunostimulant | 0.246 0.098 DBMET01949 0.23 0.105 DBMET01951 | DBMET01949 | |
| 0.112 | 0.262 | 0.141 | Heat shock protein 70 antagonist | 0.141 0.07 DBMET01953 | DBMET01953 | |
| 0.082 | 0.233 | 0.188 | Interleukin antagonist | 0.158 0.112 DBMET01952 0.188 0.091 DBMET01951 | DBMET01951 | |
| 0.106 | 0.258 | 0.154 | Neurotensin receptor agonist | 0.154 0.092 DBMET01950 0.138 0.133 DBMET01953 | DBMET01950 | |
| 0.112 | 0.265 | 0.299 | Superoxide dismutase inhibitor | 0.299 0.051 DBMET01950 0.276 0.06 DBMET01953 | DBMET01950 | |
| 0.051 | 0.203 | 0.148 | GABA C receptor rho-1 antagonist | 0.099 0.064 DBMET01951 0.148 0.022 DBMET01953 | DBMET01953 | |
| 0.145 | 0.299 | 0.262 | GABA C receptor rho-3 antagonist | 0.244 0.16 DBMET01952 0.262 0.144 DBMET01953 | DBMET01953 | |
| 0.02 | 0.18 | 0.077 | Phosphofructokinase-1 inhibitor | 0.077 0.043 DBMET01953 | DBMET01953 | |
| 0.06 | 0.22 | 0.104 | Aldehyde dehydrogenase inhibitor | 0.101 0.096 DBMET01951 0.104 0.091 DBMET01953 | DBMET01953 | |
| 0.027 | 0.19 | 0.092 | Carbonic anhydrase XIII inhibitor | 0.092 0.042 DBMET01953 | DBMET01953 | |
| 0.022 | 0.186 | 0.082 | HIV-1 integrase (3'-Processing) inhibitor | 0.082 0.033 DBMET01953 | DBMET01953 | |
| 0.048 | 0.219 | 0.155 | Xanthine oxidase inhibitor | 0.155 0.033 DBMET01953 | DBMET01953 | |
| 0.012 | 0.183 | 0.059 | Angiotensin AT1 receptor antagonist | 0.059 0.007 DBMET01953 | DBMET01953 | |
| 0.049 | 0.223 | 0.169 | Amylase inhibitor | 0.169 0.056 DBMET01949 0.14 0.069 DBMET01951 | DBMET01949 | |
| 0.033 | 0.213 | 0.073 | Interferon inducer | 0.073 0.031 DBMET01951 0.069 0.036 DBMET01953 | DBMET01951 | |
| 0.015 | 0.196 | 0.045 | Retinoic acid alpha receptor agonist | 0.045 0.019 DBMET01953 | DBMET01953 | |
| 0.015 | 0.196 | 0.046 | Carbonic anhydrase XIV inhibitor | 0.046 0.038 DBMET01953 | DBMET01953 | |
| 0.02 | 0.202 | 0.056 | Aconitate hydratase inhibitor | 0.056 0.031 DBMET01953 | DBMET01953 | |
| 0.012 | 0.194 | 0.05 | Angiotensin II receptor antagonist | 0.05 0.007 DBMET01953 | DBMET01953 | |
| 0.01 | 0.192 | 0.038 | NMDA receptor subunit 3A antagonist | 0.038 0.027 DBMET01953 | DBMET01953 | |
| 0.024 | 0.208 | 0.077 | Na+ K+ transporting ATPase inhibitor | 0.072 0.058 DBMET01951 0.077 0.053 DBMET01953 | DBMET01953 | |
| 0.031 | 0.221 | 0.136 | GABA aminotransferase inhibitor | 0.081 0.045 DBMET01950 0.136 0.011 DBMET01953 | DBMET01953 | |
| 0.102 | 0.294 | 0.288 | Histone acetyltransferase inhibitor | 0.222 0.042 DBMET01952 0.181 0.098 DBMET01951 0.288 0.016 DBMET01953 | DBMET01953 | |
| 0.014 | 0.207 | 0.071 | Neuraminidase inhibitor | 0.056 0.048 DBMET01949 0.071 0.033 DBMET01951 0.068 0.035 DBMET01953 | DBMET01951 | |
| 0.018 | 0.214 | 0.05 | Beta 2 adrenoreceptor antagonist | 0.05 0.037 DBMET01949 | DBMET01949 | |
| 0.074 | 0.27 | 0.212 | DNA methylase inhibitor | 0.174 0.097 DBMET01951 0.212 0.072 DBMET01953 | DBMET01953 | |
| 0.017 | 0.214 | 0.053 | AICAR transformylase inhibitor | 0.053 0.019 DBMET01953 | DBMET01953 | |
| 0.007 | 0.204 | 0.04 | AMPA 2 receptor antagonist | 0.04 0.014 DBMET01953 | DBMET01953 | |
| 0.032 | 0.23 | 0.085 | Interferon agonist | 0.085 0.044 DBMET01951 0.081 0.051 DBMET01953 | DBMET01951 | |
| 0.043 | 0.242 | 0.112 | GABA C receptor antagonist | 0.112 0.061 DBMET01953 | DBMET01953 | |
| 0.051 | 0.251 | 0.216 | Psychostimulant | 0.216 0.072 DBMET01949 | DBMET01949 | |
| 0.054 | 0.254 | 0.104 | Cathepsin H inhibitor | 0.104 0.1 DBMET01953 | DBMET01953 | |
| 0.034 | 0.236 | 0.101 | Potassium channel activator | 0.101 0.046 DBMET01950 | DBMET01950 | |
| 0.044 | 0.249 | 0.069 | MDM2 inhibitor | 0.069 0.042 DBMET01953 | DBMET01953 | |
| 0.05 | 0.256 | 0.109 | Carbonic anhydrase XV inhibitor | 0.109 0.057 DBMET01953 | DBMET01953 | |
| 0.045 | 0.251 | 0.171 | Alkaline phosphatase inhibitor | 0.171 0.047 DBMET01953 | DBMET01953 | |
| 0.02 | 0.234 | 0.042 | DNA gyrase subunit A inhibitor | 0.042 0.03 DBMET01953 | DBMET01953 | |
| 0.103 | 0.318 | 0.218 | DNA synthesis inhibitor | 0.196 0.129 DBMET01949 0.178 0.157 DBMET01950 0.198 0.127 DBMET01951 0.218 0.097 DBMET01953 | DBMET01953 | |
| 0.126 | 0.343 | 0.378 | Antibacterial | 0.378 0.087 DBMET01950 0.237 0.189 DBMET01951 0.355 0.099 DBMET01953 | DBMET01950 | |
| 0.104 | 0.322 | 0.146 | Ca2+-transporting ATPase inhibitor | 0.146 0.053 DBMET01950 0.135 0.096 DBMET01953 | DBMET01950 | |
| 0.006 | 0.225 | 0.037 | Kainate receptor 2 antagonist | 0.037 0.024 DBMET01950 | DBMET01950 | |
| 0.037 | 0.257 | 0.065 | Transcription factor RelA inhibitor | 0.065 0.041 DBMET01953 | DBMET01953 | |
| 0.006 | 0.226 | 0.036 | HMG CoA reductase inhibitor | 0.036 0.021 DBMET01951 | DBMET01951 | |
| 0.032 | 0.252 | 0.091 | Aminopeptidase B inhibitor | 0.091 0.072 DBMET01950 0.082 0.08 DBMET01953 | DBMET01950 | |
| 0.02 | 0.242 | 0.069 | Neuraminidase (influenza) inhibitor | 0.059 0.057 DBMET01949 0.069 0.036 DBMET01951 0.065 0.043 DBMET01953 | DBMET01951 | |
| 0.003 | 0.226 | 0.018 | Kainate receptor 1 antagonist | 0.018 0.017 DBMET01950 | DBMET01950 | |
| 0.021 | 0.244 | 0.058 | CDC25B inhibitor | 0.058 0.053 DBMET01953 | DBMET01953 | |
| 0.055 | 0.279 | 0.277 | Dual specificity phosphatase 3 inhibitor | 0.126 0.121 DBMET01952 0.152 0.095 DBMET01950 0.152 0.095 DBMET01951 0.277 0.033 DBMET01953 | DBMET01953 | |
| 0.067 | 0.295 | 0.168 | Platelet adhesion inhibitor | 0.168 0.09 DBMET01952 0.152 0.103 DBMET01951 0.165 0.091 DBMET01953 | DBMET01952 | |
| 0.084 | 0.313 | 0.147 | ATPase inhibitor | 0.147 0.106 DBMET01949 0.136 0.129 DBMET01951 | DBMET01949 | |
| 0.028 | 0.26 | 0.074 | Bcl2 antagonist | 0.074 0.038 DBMET01953 | DBMET01953 | |
| 0.048 | 0.283 | 0.099 | D-Ala-D-Ala ligase inhibitor | 0.099 0.03 DBMET01953 | DBMET01953 | |
| 0.04 | 0.282 | 0.085 | Calcium channel P-type blocker | 0.06 0.057 DBMET01952 0.085 0.011 DBMET01951 0.069 0.031 DBMET01953 | DBMET01951 | |
| 0.019 | 0.261 | 0.09 | Monophenol monooxygenase inhibitor | 0.09 0.083 DBMET01953 | DBMET01953 | |
| 0.049 | 0.291 | 0.127 | Toll-Like receptor 2 antagonist | 0.102 0.101 DBMET01949 0.127 0.07 DBMET01951 | DBMET01951 | |
| 0.041 | 0.288 | 0.114 | Carbonic anhydrase III inhibitor | 0.114 0.048 DBMET01953 | DBMET01953 | |
| 0.065 | 0.314 | 0.128 | NOS3 expression enhancer | 0.128 0.101 DBMET01953 | DBMET01953 | |
| 0.026 | 0.277 | 0.07 | Macrophage migration inhibitory factor inhibitor | 0.07 0.067 DBMET01953 | DBMET01953 | |
| 0.093 | 0.346 | 0.201 | Gastrin inhibitor | 0.191 0.162 DBMET01950 0.201 0.147 DBMET01953 | DBMET01953 | |
| 0.017 | 0.27 | 0.065 | Sphingosine 1-phosphate receptor 4 agonist | 0.065 0.049 DBMET01953 | DBMET01953 | |
| 0.034 | 0.288 | 0.114 | HIV-1 integrase (Overall Integration) inhibitor | 0.114 0.044 DBMET01950 | DBMET01950 | |
| 0.109 | 0.363 | 0.293 | Sodium/bile acid cotransporter inhibitor | 0.203 0.184 DBMET01949 0.274 0.103 DBMET01950 0.247 0.131 DBMET01951 0.293 0.085 DBMET01953 | DBMET01953 | |
| 0.008 | 0.265 | 0.046 | Ornithine carbamoyltransferase inhibitor | 0.046 0.044 DBMET01950 | DBMET01950 | |
| 0.011 | 0.268 | 0.044 | NMDA receptor subunit 3B antagonist | 0.044 0.031 DBMET01953 | DBMET01953 | |
| 0.045 | 0.307 | 0.327 | Pyruvate kinase inhibitor | 0.232 0.067 DBMET01952 0.173 0.098 DBMET01951 0.327 0.041 DBMET01953 | DBMET01953 | |
| 0.011 | 0.274 | 0.079 | Xanthine dehydrogenase inhibitor | 0.079 0.025 DBMET01953 | DBMET01953 | |
| 0.029 | 0.293 | 0.058 | Ryanodine receptor antagonist | 0.058 0.045 DBMET01953 | DBMET01953 | |
| 0.057 | 0.329 | 0.206 | Hexokinase inhibitor | 0.165 0.062 DBMET01951 0.206 0.032 DBMET01953 | DBMET01953 | |
| 0.012 | 0.293 | 0.073 | Prostaglandin-E synthase inhibitor | 0.073 0.045 DBMET01953 | DBMET01953 | |
| 0.047 | 0.331 | 0.233 | Dual specificity phosphatase inhibitor | 0.146 0.098 DBMET01950 0.233 0.042 DBMET01953 | DBMET01953 | |
| 0.017 | 0.302 | 0.085 | Glutamate decarboxylase inhibitor | 0.085 0.039 DBMET01953 | DBMET01953 | |
| 0.05 | 0.336 | 0.134 | Heat shock protein 90 alpha antagonist | 0.134 0.106 DBMET01953 | DBMET01953 | |
| 0.023 | 0.315 | 0.108 | Purinergic P2X1 antagonist | 0.058 0.046 DBMET01950 0.108 0.014 DBMET01953 | DBMET01953 | |
| 0.016 | 0.312 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.031 DBMET01953 | DBMET01953 | |
| 0.07 | 0.369 | 0.24 | Lipoxygenase inhibitor | 0.185 0.157 DBMET01952 0.24 0.106 DBMET01953 | DBMET01953 | |
| 0.109 | 0.41 | 0.191 | Tyrosine 3 hydroxylase inhibitor | 0.191 0.153 DBMET01950 | DBMET01950 | |
| 0.011 | 0.313 | 0.057 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.057 0.043 DBMET01953 | DBMET01953 | |
| 0.011 | 0.313 | 0.035 | Glutamate (mGluR3) agonist | 0.035 0.017 DBMET01950 | DBMET01950 | |
| 0.025 | 0.333 | 0.106 | Cholesterol synthesis inhibitor | 0.106 0.08 DBMET01953 | DBMET01953 | |
| 0.004 | 0.322 | 0.041 | Retinoid X receptor agonist | 0.041 0.022 DBMET01953 | DBMET01953 | |
| 0.038 | 0.359 | 0.159 | Toll-Like receptor antagonist | 0.159 0.049 DBMET01951 0.123 0.08 DBMET01953 | DBMET01951 | |
| 0.073 | 0.396 | 0.199 | Transcription factor STAT3 inhibitor | 0.199 0.135 DBMET01953 | DBMET01953 | |
| 0.025 | 0.351 | 0.105 | Creatine kinase inhibitor | 0.1 0.06 DBMET01950 0.105 0.054 DBMET01953 | DBMET01953 | |
| 0.006 | 0.341 | 0.048 | Retinoid X alpha receptor agonist | 0.048 0.015 DBMET01953 | DBMET01953 | |
| 0.032 | 0.369 | 0.127 | Alpha-N-acetylglucosaminidase inhibitor | 0.127 0.071 DBMET01953 | DBMET01953 | |
| 0.058 | 0.401 | 0.292 | DNA damaging | 0.212 0.106 DBMET01952 0.27 0.07 DBMET01951 0.292 0.06 DBMET01953 | DBMET01953 | |
| 0.087 | 0.436 | 0.467 | Histamine release inhibitor | 0.39 0.081 DBMET01949 0.351 0.1 DBMET01950 0.467 0.042 DBMET01951 0.369 0.091 DBMET01953 | DBMET01951 | |
| 0.004 | 0.355 | 0.043 | Urate transporter 1 inhibitor | 0.043 0.023 DBMET01953 | DBMET01953 | |
| 0.059 | 0.417 | 0.147 | Phospholipase C inhibitor | 0.147 0.112 DBMET01953 | DBMET01953 | |
| 0.079 | 0.437 | 0.164 | Catenin beta inhibitor | 0.155 0.094 DBMET01951 0.164 0.076 DBMET01953 | DBMET01953 | |
| 0.008 | 0.367 | 0.057 | Nerve growth factor antagonist | 0.057 0.011 DBMET01953 | DBMET01953 | |
| 0.01 | 0.369 | 0.04 | AMPA 4 receptor antagonist | 0.04 0.026 DBMET01950 | DBMET01950 | |
| 0.027 | 0.386 | 0.16 | Protein-tyrosine phosphatase inhibitor | 0.16 0.069 DBMET01953 | DBMET01953 | |
| 0.004 | 0.368 | 0.091 | AMPA receptor antagonist | 0.091 0.014 DBMET01953 | DBMET01953 | |
| 0.018 | 0.383 | 0.087 | Alcohol dehydrogenase inhibitor | 0.087 0.068 DBMET01953 | DBMET01953 | |
| 0.004 | 0.37 | 0.029 | AMPA 3 receptor antagonist | 0.029 0.021 DBMET01953 | DBMET01953 | |
| 0.019 | 0.39 | 0.221 | Glutamate receptor antagonist | 0.102 0.094 DBMET01952 0.122 0.072 DBMET01951 0.221 0.02 DBMET01953 | DBMET01953 | |
| 0.115 | 0.488 | 0.371 | 5 Hydroxytryptamine release inhibitor | 0.264 0.209 DBMET01949 0.325 0.138 DBMET01950 0.34 0.124 DBMET01951 0.371 0.098 DBMET01953 | DBMET01953 | |
| 0.064 | 0.445 | 0.128 | Sphingosine 1-phosphate receptor 5 antagonist | 0.128 0.105 DBMET01950 | DBMET01950 | |
| 0.059 | 0.443 | 0.247 | Immunosuppressant | 0.247 0.15 DBMET01951 0.206 0.191 DBMET01953 | DBMET01951 | |
| 0.015 | 0.4 | 0.109 | 5-Lipoxygenase inhibitor | 0.109 0.057 DBMET01953 | DBMET01953 | |
| 0.022 | 0.409 | 0.145 | Ferrochelatase inhibitor | 0.145 0.04 DBMET01950 0.135 0.045 DBMET01953 | DBMET01950 | |
| 0.029 | 0.439 | 0.079 | NADH dehydrogenase inhibitor | 0.079 0.077 DBMET01953 | DBMET01953 | |
| 0.022 | 0.439 | 0.065 | Potassium channel large-conductance Ca-activated activator | 0.065 0.05 DBMET01953 | DBMET01953 | |
| 0.02 | 0.451 | 0.1 | GABA C receptor agonist | 0.1 0.067 DBMET01950 0.089 0.08 DBMET01953 | DBMET01950 | |
| 0.022 | 0.457 | 0.096 | Uric acid excretion stimulant | 0.096 0.057 DBMET01953 | DBMET01953 | |
| 0.003 | 0.438 | 0.029 | Methionyl aminopeptidase 2 inhibitor | 0.029 0.014 DBMET01953 | DBMET01953 | |
| 0.018 | 0.456 | 0.122 | Potassium channel (Ca-activated) activator | 0.122 0.04 DBMET01953 | DBMET01953 | |
| 0.128 | 0.567 | 0.312 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.312 0.197 DBMET01953 | DBMET01953 | |
| 0.014 | 0.457 | 0.066 | Glutamate (mGluR group I) antagonist | 0.066 0.053 DBMET01953 | DBMET01953 | |
| 0.098 | 0.546 | 0.198 | 5 Hydroxytryptamine uptake stimulant | 0.198 0.156 DBMET01950 | DBMET01950 | |
| 0.004 | 0.454 | 0.015 | Calcium-sensing receptor antagonist | 0.015 0.01 DBMET01951 | DBMET01951 | |
| 0.08 | 0.536 | 0.136 | CC chemokine 6 receptor antagonist | 0.136 0.051 DBMET01953 | DBMET01953 | |
| 0.017 | 0.489 | 0.094 | Protein kinase C gamma inhibitor | 0.094 0.088 DBMET01953 | DBMET01953 | |
| 0.022 | 0.495 | 0.106 | Bone formation stimulant | 0.106 0.1 DBMET01951 | DBMET01951 | |
| 0.03 | 0.506 | 0.139 | NADPH oxidase inhibitor | 0.139 0.063 DBMET01953 | DBMET01953 | |
| 0.011 | 0.51 | 0.074 | HIV-1 integrase inhibitor | 0.074 0.044 DBMET01953 | DBMET01953 | |
| 0.01 | 0.515 | 0.151 | Glycogen synthase kinase-3 alpha inhibitor | 0.151 0.066 DBMET01953 | DBMET01953 | |
| 0.01 | 0.541 | 0.081 | Glutamate (mGluR) antagonist | 0.081 0.048 DBMET01953 | DBMET01953 | |
| 0.009 | 0.721 | 0.173 | Hypolipemic | 0.173 0.115 DBMET01951 | DBMET01951 | |
| 0.041 | 0.768 | 0.105 | Sphingosine 1-phosphate receptor 2 agonist | 0.105 0.088 DBMET01951 | DBMET01951 | |
| 0.022 | 0.781 | 0.237 | Hypoglycemic | 0.237 0.085 DBMET01951 0.179 0.135 DBMET01953 | DBMET01951 | |
| 0.008 | 0.903 | 0.146 | Insulin secretagoues | 0.146 0.079 DBMET01951 | DBMET01951 | |
| 0.006 | 0.917 | 0.278 | Cyclophilin D inhibitor | 0.278 0.183 DBMET01951 | DBMET01951 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |